Our seasoned team of advisors combines strategic, financial, and operational experience to help organizations of every size achieve their objectives. Our work with both esteemed healthcare institutions and emerging healthtech startups provides us a distinct perspective on the sector’s horizon line.
Our consultants possess significant advisory, operational, and financial experience with healthcare businesses and organizations of all types and sizes (see representative engagements below), empowering a practical “just get it done” perspective that drives successful outcomes.
IWe recognize that every client is unique. Our solutions are customized to fit your specific challenges, goals, and resources.
With a history of delivering impactful results, we’ve helped numerous healthcare organizations achieve their goals and overcome their challenges.
We stay up-to-date with the latest trends and technologies in the healthcare industry, ensuring that our clients remain competitive and at the forefront of innovation.
The success of our clients is our enduring priority. We work collaboratively with your team, keeping communication open and transparent throughout the consulting process.
ANGELINI PHARMA is a €1.9 BN pharma group with offices in 20 countries and employing over 6,000 employees. The U.S. subsidiary, Angelini Pharma Inc., has a dominant position in dialysis infection prevention.
SCOPE: Growthink was engaged by Angelini Pharma, Inc. to drive the preparation of a five year growth plan to organically grow revenues from $12M to $40M.
IMPACT: The research and strategy phase of the project identified 4 adjacent submarkets where the company can penetrate with minor additions to the current product portfolio. The growth plan has been presented to the ParentCo receiving positive feedback. With the approval of the initiatives and budget, the Company is transitioning into the execution phase.
Through a multidisciplinary team of industry, regulatory, and scientific specialists, Lachman Consultants helps organizations to prevent and resolve compliance problems and to develop efficient and effective strategies for the submission and approval by the FDA for drugs, biologics, and devices.
SCOPE and IMPACT: Conducted market research and created a series of white papers that the Company uses to Communicate their ability to provide services in new niches & to Generate leads and inquiries from new prospects as well as existing clients. The white papers combined qualitative components (best practices, industry trends, regulatory environment) with quantitative elements (prospective opportunity costs related to data integrity, delayed market entry, delayed product launch, missed leadership position, financing costs, fines and regulatory costs).
is one of the oldest and most prestigious hospitals in Los Angeles with a $200M/year operating budget.
SCOPE: Moderated series of strategic retreats with eight-person executive team to determine best direction on process, team, capital and union issues.
IMPACT: Aligned executive team on top 3-5 quarterly and annual priorities related to service lines, cost management and strategic partnerships.
NOVIS HEALTH is a holistic data-driven wellness company that provides individualized physician-built programs, effective health coaching, and personalized supplements, for a patient experience far superior to anything offered in traditional healthcare.
SCOPE: Growthink was engaged to capture the founders’ vision, explore market dynamics and identify growth opportunities, as well as to create a go-to-market strategy and investor offering package.
IMPACT: Following the strategic planning process with Growthink, Novis Health pivoted from brick-and-mortar to a virtual/telehealth business model, as well as from in-office services to a product centric business. The company now has its own supplement brand with proprietary formulations and a lean service model that can scale quickly in a responsible and capital efficient manner.
MELAX TECH is a healthcare data analytics and business intelligence company focused on Natural Language Processing (NLP) to provide healthcare organizations with actionable insights into clinical and financial performance.
SCOPE: Growthink was engaged to develop financial projections and a go-to-market story and pitch deck for the firm.
IMPACT: Melax Tech has been acquired by Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare. The acquisition expanded IMO’s suite of products to improve patient care, clinical workflows, and healthcare data quality.
Call us or complete the form below and one of our experts will reach out to you to schedule a time to speak.